Targeted Therapies in Oncology
November 2013
Volume: 2
Issue: 6
September 2013
Volume: 2
Issue: 5
July 2013
Volume: 2
Issue: 4
May 2013
Volume: 2
Issue: 3
March 2013
Volume: 2
Issue: 2
January 2013
Volume: 2
Issue: 1
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
3
Pelareorep Offers Promise in Second-Line KRAS-Mutant Metastatic CRC
4
Phase 3 Data Highlight Orca-T’s Clinical Benefits in Heme Malignancies
5